Mass Spectra of Designer Drugs 2010

Mass Spectra of Designer Drugs 2010

Product Information
Compounds classified as Designer Drugs have been synthesized since the early 1980s. This is not a precise scientific term and should only be applied to those drugs that are synthesized from common chemicals and skillfully marketed under attractive, often exotic names. The last decade has seen a proliferation of such substances, such that keeping abreast of this huge number of new drugs is a difficult task for forensic chemists and toxicologists.
The Designer Drugs 2010 cover the entire range of designer drugs up to December 2009. Carefully compiled by the mass spectral experts at the Regional Departments of Criminal Investigation in Kiel, Hamburg, and Wiesbaden, Germany, this database includes:

• 10,450 chemical compounds
• 12,312 mass spectra, about 1,300 more spectra than the 2009 edition
• Chemical structures
• Chemical warfare agents, added due to the interest in homeland security
• Data taken from both legal and underground literature, providing the most comprehensive picture of these compounds
• Average peaks per spectrum: 161
• Average Quality Index: 938
• Experimental Kovats indices: 5866
• Calculated Kovats indices

NEW: LC-MS has become a powerful technique in clinical and forensic toxicology due to its high sensitivity and specificity. In addition to the 12,312 mass spectra of the GC-MS collection 5,986 ESI LC-MS/MS spectra of about 500 compounds have been added to the 2010 edition as a separate database.

The LC-MS data are a valuable and complementary supplement to the GC-MS collection. The spectra have been acquired under standardized conditions and are fully searchable.

Compound Classes

Class		Number
amphetamines		1030
methylenedioxyphenethylamines		533
phenethylamines		1340
tryptamines		317
piperazines		361
opiates		233
fentanyles		320
cathinones		267
phencyclidines		14
tropines		73
indoles		145
barbiturates		58
cannabinoids		84
cannabimimetics		57
steroids		63
arylpropan-2-amines		109
arylbutan-2-amines		394
1-aryl-2-nitro-ethenes		41
1-aryl-2-nitroprop-1-enes		65
1-aryl-2-nitrobut-1-ene		44
benzaldehydes		141
designer drug isomers		606
derivatives		3587
metabolites incl. derivatives		2596
chemical warfare agents		67
designer drug precursors		639
pharmaceutical drugs incl. metabolites		3357
pesticides		199
explosives		25
controlled compounds		1148

Available Database Formats
ACD; Agilent Chemstation; NIST MSSEARCH; Finnigan GCQ, SSQ, TSQ, ICIS, ITS40, Magnum; INCOS; PE Turbomass; Shimadzu QP-5000; Thermo Galactic SpectralID; Varian Saturn;VG Labbase, Masslab; Waters Masslynx; Xcalibur

Market
Organic chemists involved in structure elucidation; Spectroscopists; Chemical and pharmaceutical companies; Chemistry, biochemistry and pharmaceutical faculties; Governmental institutions; Crime laboratories; Doping control laboratories.

Editors

Peter Rösner (born 1944) studied Chemistry at the University of Kiel (Germany). In 1981 he became head of the toxicology department at the state agency of criminal investigation (Landeskriminalamt) in Kiel, where he focuses on drug identification and structure elucidation with GC/MS methods. Since 1992 he has also been a lecturer for mass spectrometry at the University of Kiel. In 2005, Dr. Rösner received the Jean-Servais-Stas Award from the Society of Toxicological and Forensic Chemistry in honor of his outstanding work in forensic sciences.

Thomas Junge (born 1959) studied Technical Chemistry at the University of Applied Science of Lübeck (Germany). Since 1985 he has been a specialist for daughter ion mass spectrometry in the toxicology department at the Landeskriminalamt in Kiel. His contribution was essential in building up a daughter ion mass spectral data base for the structure eludication of new designer drugs.

Folker Westphal (born 1965), studied Chemistry at the Universities of Hannover and Kiel (Germany), and also holds a degree as Special Chemist for Toxicology from the University of Leipzig. From 1999 to 2004 he worked at the Institute of Legal Medicine in Kiel as forensic scientist. Since 2004 he is leader of the section "Analysis of Drugs of Abuse and Forensic Toxicology" at the Landeskriminalamt in Kiel.

Giselher Fritschi (born 1944) studied Chemistry at the Universities of Mainz and Karlsruhe (Germany). After a postdoc year at the University of Marburg he joined the Bundesgesundheitsamt (Federal Health Office) in Frankfurt. In 1978 he changed to the Landeskriminalamt in Wiesbaden as forensic expert for toxicological analysis, focusing on the structure elucidation of new designer drugs.

©2010 Wiley-VCH Verlag GmbH & Co. KGaA - Provider
http://www.wiley-vch.de
Data Protection
Last Update: 19-Mar-2010